IP Patent News » European

* PDL says gets Genentech letter on European patents – Reuters

admin — Mon, 16 Aug 2010 03:25:23 +0000

Town Hall
* PDL says gets Genentech letter on European patents
Reuters
O), which licenses its technology to Genentech, said the biotech giant has claimed its drugs do not infringe PDL’s European patents, throwing into doubt …
PDL tumbles; Trubion rallies on buyout offerMarketWatch
PDL BioPharma tumbles on patent dispute. FDA approves “morning after” pillBioMedReports (subscription)
PDL BioPharma Receives Letter from Genentech Relating to European PatentsPR Newswire (press release)
The Associated Press

Broccoli, tomatoes in landmark patent case – AFP

admin — Wed, 21 Jul 2010 00:53:09 +0000

SAMAA TV
Broccoli, tomatoes in landmark patent case
AFP
MUNICH, Germany ‘

Monsanto Loses After EU Court Decides that Soy Meal No Longer Has Functional DNA

admin — Thu, 08 Jul 2010 18:47:33 +0000

[Story ID: 2728]

The European Court of Justice in Luxembourg ruled against Monsanto Co. stating that ‘

EPO Sees Double (Patenting)

admin — Wed, 02 Jun 2010 17:08:06 +0000

[Story ID: 2134]

If an authority grants two patents for the same invention to the same applicant, that is double patenting. In most European states the law requires that one of the patents must cease.
Since it started, the European Patent Office (EPO) official view has been that it should not allow double patenting. The Guidelines for Examination explicitly [...]

Related posts:EPO: Dosage Regime Patentable Even If It is The Only Novel Feature The therapeutic use of that substance cannot be patented because…
Just a Reminder: EPO Fees Increase April 1 The European Patent Office (“EPO”) recently announced that most of…
EPO Enlarged Board of Appeal: Method Patentable By Disclaiming Unpatentable Step The EPO Enlarged Board of Appeal handed down its decision…

Related posts brought to you by Yet Another Related Posts Plugin.

EpiCept announces U.K. launch of Ceplene

admin — Tue, 20 Apr 2010 04:35:00 +0000

[Story ID: 1405]

EpiCept Corporation today announced that the commercial launch of Ceplene® (histamine dihydrochloride) will take place in the United Kingdom on April 20, 2010 in conjunction with the British Society for Haematology 50th Annual Scientific Meeting in Edinburgh, Scotland. Ceplene is approved in the European Union for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first remission.

BIOTRONIK receives European approval for new ProMRI Pacing Systems

admin — Thu, 08 Apr 2010 04:37:45 +0000

[Story ID: 1198]

BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the European approval of its new ProMRI Pacing Systems ‘

Pluristem Therapeutics receives European Patent on core 3D cell expansion technology (News-Medical-Net)

admin — Tue, 23 Mar 2010 14:00:49 +0000

[Story ID: 960]

Pluristem Therapeutics Inc. today announced that it has been granted a European Patent on its core 3D cell expansion technology. The granting of the European patent follows the issuance of several corresponding US patents as well as corresponding patents in ten additional jurisdictions.

Just a Reminder: EPO Fees Increase April 1

admin — Mon, 22 Feb 2010 19:23:08 +0000

[Story ID: 542]

The European Patent Office (“EPO”) recently announced that most of its fees will increase by between 5 and 8 per cent from April 1, 2010. A summary of the new fees is shown here.
What does this all mean to you?
If you know that you want to enter the European regional phase of a PCT application, [...]

Related posts:EPO Rule Changes: Speeding Prosecution The European Patent Office (EPO) has announced more important rule…
Filing Patent Applications Early in Europe Could Save You Money On April 1, the European Patent Office changes the fee…
Changes in the Implementing Rules of the European Patent Convention (EPC) The Administrative Council of the EPO decided, in March 2009,…

Related posts brought to you by Yet Another Related Posts Plugin.

Changes in the Implementing Rules of the European Patent Convention (EPC)

admin — Tue, 02 Feb 2010 19:33:41 +0000

[Story ID: 163]

The Administrative Council of the EPO decided, in March 2009, to make significant changes to the Implementing Rules of the European Patent Convention (EPC). These changes will enter into force on April 1, 2010 and will have a significant impact on the grant procedure before the EPO.
Introduction of a new time limit for filing divisional [...]

Related posts:European Patent Office Decides Divisional Applications Are Abusive There have been mutterings and papers for some time about…
EPO Rule Changes: Speeding Prosecution The European Patent Office (EPO) has announced more important rule…
Filing Patent Applications Early in Europe Could Save You Money On April 1, the European Patent Office changes the fee…

Related posts brought to you by Yet Another Related Posts Plugin.